Lonza's (SGX:O6Z) attributable profit to equity holders during the first half of the year rose to 591 million Swiss francs from 426 million francs a year earlier, according to a Wednesday filing with the Singapore Exchange.
Earnings per share rose to 8.16 francs compared with 5.67 francs in the year-ago period.
The Swiss pharmaceutical company's sales rose 11% year over year to 3.37 billion francs from 3.03 billion francs.